clarithromycin has been researched along with Gout in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Franklin, JM; Kesselheim, AS; Kim, SC; Seeger, JD; Solomon, DH | 1 |
| McKinnell, J; Tayek, JA | 1 |
2 other study(ies) available for clarithromycin and Gout
| Article | Year |
|---|---|
Reductions in Use of Colchicine after FDA Enforcement of Market Exclusivity in a Commercially Insured Population.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Colchicine; Drug Approval; Drug Costs; Drug Interactions; Drug Prescriptions; Drug Utilization; Economic Competition; Familial Mediterranean Fever; Female; Gout; Gout Suppressants; Health Care Costs; Humans; Insurance, Health; Male; Middle Aged; Retrospective Studies; United States; United States Food and Drug Administration | 2015 |
Short term treatment with clarithromycin resulting in colchicine-induced rhabdomyolysis.
Topics: Anti-Bacterial Agents; Ceftriaxone; Clarithromycin; Colchicine; Community-Acquired Infections; Doxycycline; Drug Interactions; Gout; Gout Suppressants; Humans; Male; Middle Aged; Pneumonia, Bacterial; Rhabdomyolysis; Treatment Outcome | 2009 |